Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Microchip Technology Appoints Long-Time TSMC Executive Rick Cassidy to Its Board of Directors
-
COMSTOCK RESOURCES, INC. ANNOUNCES DUAL LISTING ON NYSE TEXAS
-
Credicorp Ltd.: Credicorp’s Earnings Release and Conference Call 1Q25
-
Enbridge Provides Notice of Series 13 Preferred Shares Conversion Right and Announces Reset Dividend Rates
-
NXP Announces Availability of Proxy Materials for the Annual General Meeting of Shareholders to Be Held on June 11, 2025
-
TransCode Therapeutics Announces 1-for-28 Reverse Stock Split
-
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Bon Natural Life Limited Announces Receipt of Nasdaq Delisting Notifications
-
Dover Declares Regular Quarterly Cash Dividend
-
XRP News: Buy $XDX Tokens Now Before XenDex Presale Ends Soon, as XRP Market Heats Up
-
Mogo to Announce Q1 2025 Financial Results May 8, 2025
-
Purple Innovation to Report First Quarter 2025 Results on May 6, 2025
-
Raines Congratulates Four Partners Named to Billboard Magazine’s 2025 Top Music Lawyers; Elliot A. Resnik Elevated to Department Co-Chair
-
Update on Market Making Arrangements
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Jushi Holdings Inc. Updates Call Time to 4:00 p.m. Eastern Time to Report First Quarter 2025 Financial Results on May 8, 2025
-
NurExone Expands European Engagement with Investor Events in Germany and Switzerland
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
Taitron Announces Quarterly Cash Dividend
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Mesabi Trust Press Release
-
Cipher Mining Announces April 2025 Operational Update
-
U.S. Global Investors Announces Third Quarter of Fiscal 2025 Webcast
-
Concorde International Group Announces Underwriter’s Full Exercise and Closing of Over-allotment Option
-
Copley Acquisition Corp Announces Closing of $172,500,000 Initial Public Offering
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
EVERTEC Declares Quarterly Dividend on Common Stock
-
Greenlight Capital Re, Ltd. Schedules First Quarter 2025 Financial Results and Conference Call
-
ITC Makes Affirmative Preliminary Determination in Trade Cases on Fiberglass Door Panels from China, Wiley Rein LLP Reports
-
Iovance Biotherapeutics to Host First Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, May 8, 2025
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
Premium Income Corporation Announces Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Subsea7 awarded ‘super-major’ contract offshore Brazil
-
Silvercrest Asset Management (SAMG) to Announce First Quarter 2025 Results and Host Investor Conference Call
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
National Healthcare Properties Announces Release Date for First Quarter 2025 Results
-
HPU Honors Graduate Students at Commencement
-
A new MEI study highlights the importance of micro-entrepreneurs in supplying drinking water to poorer neighbourhoods in Ivory Coast
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
First Horizon Celebrates Ribbon Cutting of Appalachian State-Themed Banking Center
-
Republic Digital Acquisition Company Completes $300,000,000 Initial Public Offering
-
Spectral AI Schedules 2025 First Quarter Financial Results and Conference Call

